Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
RefMet: Reference List of Metabolite Names
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Return to Statistics Toolbox
Pathway mapping for Study ST002097
(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1
Experimental factor
Group2
Genotype/Treatment:Ad-Mieap infection (2)
Genotype/Treatment:Control (4)
Genotype/Treatment:Mieap-knockdown (4)
Genotype/Treatment:Non-infection (2)
Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil) (6)
Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil) (6)
Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil) (6)
Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil) (6)
Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil. (6)
Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil. (6)
Limit by pathway class:
Metabolic
Disease
Drug Action
Drug Metabolism
Physiological
Signaling
All
Analysis:
Reversed phase NEGATIVE ION MODE
Reversed phase POSITIVE ION MODE
Reversed phase NEGATIVE ION MODE
Combine data for all analyses?:
Metabolomics Workbench
Terms of use
Site map
Contact